Podcasts about cytology

Send me a derm question or story through text or voicemail!French Bulldogs, English Bulldogs, and other brachycephalic breeds are frequent flyers in veterinary dermatology but successfully managing their skin disease often requires looking beyond the obvious itch.In this episode of The Derm Vet Podcast, I break down some of the most common dermatologic problems seen in brachycephalic dogs, including skin fold dermatitis (intertrigo), pododermatitis, secondary infections, and underlying food and environmental allergies.Learn why examining every facial, tail, and vulvar fold matters, how cytology can guide treatment, why topical therapy is so important for both treatment and long-term maintenance, and how to build an allergy workup that is realistic for both the patient and owner.Watch The Episode: https://www.youtube.com/@thedermvet3932Follow The Derm Vet Podcast: https://www.instagram.com/thedermvetpod/Follow Me: https://www.instagram.comTimestamps00:00 Intro00:52 Itch Inquiry: Feline Ear Flushing and Horner's Syndrome Risk04:05 Fold Dermatitis and Key Fold Locations07:14 Cytology and Topical Therapies for Skin Fold Infections09:58 Pododermatitis12:48 Allergic Workups and Long-Term Inflammatory Options16:15 Overview and Final Takeaways18:03 Outro

Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Sherri M. Donat, MD Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. For more information or to subscribe to the AUA Update Series, please visit CME.auanet.org

Does catching cancer earlier with surveillance always translate to better outcomes for gynecologic cancer patients? On this episode of BackTable Women's Health, hosts Dr. Mona Guo and Dr. Marcia Ciccone interview Dr. Ritu Salani, Professor of OBGYN at UCLA and lead author of the updated SGO surveillance clinical practice statements. They discuss how post–curative-intent surveillance has evolved amid limited prospective evidence, review the latest guidelines, and highlight the real-world challenges of balancing early detection, patient safety, and cost. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction03:05 - Evolving Guidelines and Consensus10:02 - Lead-Time Bias and Cost Considerations12:05 - Maintenance Therapy and Surveillance Nuances14:44 - Ovarian and Endometrial Cancer: Imaging vs Exam20:24 - Key Takeaways from the TOTEM Trial24:04 - Future Tools, Lifestyle Counseling, and Shared Care27:21 - Cytology, HPV Testing, and Post-Radiation Surveillance31:13 - Hormone Therapy Considerations34:37 - ctDNA and MRD Testing37:39 - Emerging Technologies and Limitations43:22 - Rapid Fire Takeaways45:33 - Closing Thoughts --- More about this episode The conversation explores practice variability, the lack of clear survival benefits from routine imaging and tumor markers, and the risks of cascade testing and lead-time bias. Dr. Salani reviews the TOTEM trial data for endometrial cancer, the importance of symptom review and pelvic exams (especially for lower genital tract cancers), and the reduced role of cytology, even in cervical cancer after radiation. They also discuss shared-care models, lifestyle counseling, hormone therapy considerations, and the promise and limitations of emerging technologies like ctDNA and MRD testing during maintenance therapy. --- Resources TOTEM Trialhttps://ascopubs.org/doi/abs/10.1200/jco.22.00471 2010 Ovarian Cancer CA-125 Trialhttps://pubmed.ncbi.nlm.nih.gov/20888993/ Society of Gynecologic Oncology Clinical Practice Statement on Surveillancehttps://pubmed.ncbi.nlm.nih.gov/41308226/ --- BackTable Women's Health is the go-to podcast for gynecologists, gynecologic surgeons, and other healthcare professionals focused on women's health. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Send us Fan MailDoes more experience automatically make a cytotechnologist more accurate—or does where they look first matter more?In DigiPath Digest #50, I review a digital cytology eye-tracking study that challenges the assumption that diagnostic accuracy improves steadily with years of practice.The researchers tracked the visual behavior of 100 board-certified cytotechnologists with 1 to 40 years of experience. They found no statistically significant linear relationship between years of experience and diagnostic accuracy. Instead, low-power field efficiency—the ability to identify an important target quickly within a wider field—emerged as the key predictor of high accuracy discussed in the study.The study also examined whether this visual skill can be developed. Twenty-eight students completed an intensive three-month cytotechnology training program. After training, they located diagnostic targets more quickly and spent less attention on normal, nondiagnostic cells. In other words, they learned both where to look and what to disregard.What could this mean for digital pathology education?As AI-assisted workflows take on more of the exhaustive searching, cytotechnologists and pathologists may increasingly work as expert verifiers. That requires rapid target assessment, strong knowledge of normal morphology, and awareness of risks such as confirmation bias and cognitive fatigue.The study has an important limitation: it used static images rather than dynamic whole slide imaging. The findings raise useful questions about visual expertise, training, and competency assessment, but they shouldn't be generalized beyond the study design without further research.Episode Highlights00:00 – Welcome to DigiPath Digest #50 and introduction to the paper04:10 – Why the traditional definition of professional expertise is changing07:02 – Moving from exhaustive searching to verification in AI-assisted workflows09:04 – How eye tracking was used with 100 board-certified professionals10:25 – Years of experience versus diagnostic accuracy13:13 – Experience-based caution and attention to sample information15:16 – Low-power field efficiency as a predictor of high accuracy17:05 – Practical low-power field demonstration using a whole slide image20:15 – Searching versus detecting and the mental map of normal morphology24:04 – Comparing high- and low-performer visual scan paths25:27 – Cognitive filtering: knowing what not to examine27:35 – Can visual efficiency be taught in three months?29:55 – How AI may shift the human role from searcher to verifier30:38 – Study limitations: static images versus dynamic whole slide imaging32:37 – Could gaze efficiency influence future competency assessment?33:44 – Digital pathology learning resources and closing thoughtsResources MentionedAbstract and paper: Screening Efficiency Over Experience: Rapid Target Detection in Low-Power Field as a Modifiable Cognitive Biomarker for Diagnostic Accuracy in Digital CytologyListen to the full DigiPath Digest #50 recording to examine what the study found, what it didn't prove, and how visual search skills could influence digital cytology training. Support the showGet the "Digital Pathology 101" FREE E-book and join us!

Ear cytology gives us information that a visual examination—or even sniff test—simply cannot, yet we too often forgo this essential diagnostic step. In this episode of the Partner Podcast, Dr. Beth talks with Liz Layne, DVM, DACVD, and Christi Belew, DVM, about the role of cytology in otitis externa management. They share practical tips for interpreting samples and explore how emerging analyzer technology is bringing a new level of consistency and accuracy to in-clinic results. Sponsored by IDEXX Resource:  https://www.idexx.com/en/veterinary/analyzers/invue-dx-analyzer/test-types/ear-cytology/ Contact us: Podcast@instinct.vet Where to find us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ X: @cliniciansbrief Instagram: @clinicians.brief The Team: Beth Molleson, DVM - Host Taylor Argo- Producer, Sound Editing, & Project Manager, Brief Studio

Send us Fan MailA splenic mass shows up on ultrasound and the question hits like a brick: benign or malignant? We go straight at the uncomfortable truth behind canine splenic cytology. Even when splenic FNA feels like the “do something now” step, the match between cytology and histopathology is only moderate, and that has consequences for how we advise families, schedule rechecks, and decide when splenectomy is the safest path.We talk with Drs. Janet Grimes and Matthew Aluisio about what their data means in the exam room: why a neoplastic cytology result tends to be more predictive than a non-neoplastic one, and why a benign aspirate does not rule out cancer. We unpack the spleen's built-in complexity, including extramedullary hematopoiesis, mixed cell populations, and the sampling problem of trying to summarize a large, heterogeneous lesion from a tiny needle sample. We also get specific about the diagnoses no one wants to miss, including hemangiosarcoma and lymphoma, and how tumor exfoliation and overlap with reactive processes can blur the picture.From there, we shift into action: when cytology is most useful, when serial ultrasound monitoring is a reasonable strategy for smaller, non-ruptured nodules, and when size and rupture risk should move the conversation toward surgery and definitive histopathology. We also dig into the “possibly neoplastic” gray zone and why calling your pathologist can be one of the most practical diagnostic tools you have.If you work up splenic masses in dogs and want clearer owner conversations, better monitoring plans, and fewer false reassurances, this one is for you. Subscribe, share with a colleague, and leave a rating and review so more clinicians can find the show.JAVMA article: https://doi.org/10.2460/javma.26.01.0006INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?JAVMA ® : https://avma.org/JAVMAAuthorsAJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® :Facebook: Journal of the American Veterinary Medical Association - JAVMA | FacebookInstagram: JAVMA (@avma_javma) • Instagram photos and videosTwitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | FacebookInstagram: AJVR (@ajvroa) • Instagram photos and videosTwitter: AJVR (@AJVROA) / TwitterJAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Send us Fan MailA splenic mass shows up on ultrasound and the question hits like a brick: benign or malignant? We go straight at the uncomfortable truth behind canine splenic cytology. Even when splenic FNA feels like the “do something now” step, the match between cytology and histopathology is only moderate, and that has consequences for how we advise families, schedule rechecks, and decide when splenectomy is the safest path.We talk with Drs. Janet Grimes and Matthew Alusio about what their data means in the exam room: why a neoplastic cytology result tends to be more predictive than a non-neoplastic one, and why a benign aspirate does not rule out cancer. We unpack the spleen's built-in complexity, including extramedullary hematopoiesis, mixed cell populations, and the sampling problem of trying to summarize a large, heterogeneous lesion from a tiny needle sample. We also get specific about the diagnoses no one wants to miss, including hemangiosarcoma and lymphoma, and how tumor exfoliation and overlap with reactive processes can blur the picture.From there, we shift into action: when cytology is most useful, when serial ultrasound monitoring is a reasonable strategy for smaller, non-ruptured nodules, and when size and rupture risk should move the conversation toward surgery and definitive histopathology. We also dig into the “possibly neoplastic” gray zone and why calling your pathologist can be one of the most practical diagnostic tools you have.If you work up splenic masses in dogs and want clearer owner conversations, better monitoring plans, and fewer false reassurances, this one is for you. Subscribe, share with a colleague, and leave a rating and review so more clinicians can find the show.JAVMA article: https://doi.org/10.2460/javma.26.01.0006INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?JAVMA ® : https://avma.org/JAVMAAuthorsAJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® :Facebook: Journal of the American Veterinary Medical Association - JAVMA | FacebookInstagram: JAVMA (@avma_javma) • Instagram photos and videosTwitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | FacebookInstagram: AJVR (@ajvroa) • Instagram photos and videosTwitter: AJVR (@AJVROA) / TwitterJAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

How is the role of the cytologist evolving in today's rapidly changing laboratory landscape? In this episode, we spotlight an important initiative from the American Society of Cytopathology (ASC) Clinical Practice Committee aimed at answering that very question. Tune in as we explore a comprehensive member survey that captures the current responsibilities of cytologists—and how those roles are expanding beyond the traditional microscope. From the growing influence of digital cytology to the transformative potential of artificial intelligence, this survey seeks to understand not only what cytologists are doing today, but how they feel about the future of the profession. We also discuss why your voice matters. The insights gathered will play a critical role in identifying challenges faced by cytologists/cytotechnologists and shaping strategies to improve job satisfaction, strengthen workforce retention, support professional development, and optimize laboratory operations.   Vanda F. Torous, MD Massachusetts General Hospital Boston, Massachusetts   Nathalie Kumiega, SCT(ASCP)CM Massachusetts General Hospital Boston, Massachusetts   Catherine E. Bammert, PhD, CT, MB(ASCP), CTIAC UT MD Anderson Cancer Center Houston, Texas

Send us Fan MailDigiPath Digest #45 asks a practical question: can AI in pathology move from correlation to real clinical use? In this episode, I review four papers that push on that question from different angles: computational pathology moving toward morphology-driven molecular inference, the current state of digital cytopathology and AI, multi-omics and precision oncology in hepatocellular carcinoma, and AI literacy in veterinary education. What ties them together is not model performance alone. It is the harder question of validation, workflow fit, quantitative use, ethics, and human oversight.In the first paper, I talk about computational pathology as more than pattern recognition. The focus is on morphology-driven molecular inference, digital biomarkers, and why spatial omics matters as biological ground truth. I also discuss why continuous quantitative scoring is more useful than forcing biology into rough scoring buckets. The second paper focuses on digital cytopathology. Cytology was early for FDA-cleared AI in cervical screening, but non-gynecologic cytology is still much harder to digitize because of specimen variability and workflow complexity. I also cover telecytology, rapid onsite evaluation, automation, and quality control. The third paper looks at hepatocellular carcinoma and AI-driven precision oncology. This part is about using AI and machine learning to integrate genomics, transcriptomics, proteomics, metabolomics, radiomics, and pathology to support biomarker discovery, tumor microenvironment analysis, and treatment stratification. The fourth paper may be the most broadly useful. It proposes an AI literacy curriculum for veterinary education that covers AI fundamentals, machine learning evaluation, LLMs, ethics, liability, and academic integrity. I think that matters far beyond veterinary medicine, because if clinicians are expected to use AI tools responsibly, AI literacy cannot stay optional. Highlights 00:01 Welcome and overview of the four papers 03:02 Computational pathology and morphology-driven molecular inference 11:01 Digital cytopathology, telecytology, and QC 20:47 AI/ML in hepatocellular carcinoma precision oncology 31:04 AI literacy in veterinary education 47:42 Final takeaways and Digital Pathology 101 update ResourcesComputational Pathology as a Mechanistic Discipline: From Morphology to Molecular Data https://pubmed.ncbi.nlm.nih.gov/42052846/Advances in Digital Cytopathology and Artificial Intelligence Applications https://pubmed.ncbi.nlm.nih.gov/42046894/Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology https://pubmed.ncbi.nlm.nih.gov/42065059/Curriculum Framework for Artificial Intelligence Literacy in Veterinary Education Front Vet Sci. 2026;13:1801756 Support the showGet the "Digital Pathology 101" FREE E-book and join us!

Send us Fan MailPaper Discussed in this Episode: Can large language models like ChatGPT and Gemini interpret cervical cytology accurately? Saroja Devi Geetha. Annals of Diagnostic Pathology 2026; Volume 83, 152641.Episode Summary: In this journal club deep dive, we explore what happens when advanced artificial intelligence is thrown into the visually chaotic realm of human biology. We examine a 2026 study evaluating whether two massive multimodal models—GPT-5 and Gemini 2.5 Pro—can accurately read digital cervical Pap smears without any prior fine-tuning,,. We unpack how these general-purpose models perform on highly specialized visual tasks, revealing that while they aren't ready to fly solo, they exhibit fascinating and distinct diagnostic "personalities" that will undoubtedly reshape the future of the pathology lab,.In This Episode, We Cover:• The "Textbook" Test Setup: How researchers tested the baseline visual reasoning of GPT-5 and Gemini 2.5 Pro by feeding them 100 curated, gold-standard digital Pap test images from the Hologic Education Site to classify using the Bethesda System,,.• The Clinical Reality Check: While the models only achieved a coin-toss exact diagnostic match rate (47% for GPT-5 and 48% for Gemini), their accuracy jumped to 66% when evaluating clinical management protocols—proving they are beginning to grasp the underlying severity and medical consequences of cellular abnormalities,,.• The Over-Anxious Resident (Gemini 2.5 Pro): Gemini acted like a highly sensitive but unrefined trainee, hitting 84% sensitivity and expertly spotting infectious organisms (71%),,. However, its tendency to confuse dense, overlapping cellular clumps with high-grade squamous intraepithelial lesions (HSIL) led to massive overcalling, dragging its specificity down to 71% and creating a risk of false alarms,.• The Big-Picture Academic (GPT-5): GPT-5 proved to be much more measured, demonstrating better overall specificity (74%) and excelling at identifying subtle structural shifts like low-grade squamous intraepithelial lesions (LSIL) (75%) and glandular changes,. Yet, in its focus on the big picture, it completely missed obvious infectious organisms, scoring a dismal 20%,.• The Future of the Lab - Prompt Engineering & The Algorithmic Auditor: Why the next era of cytopathology requires rigorous AI fine-tuning on proprietary datasets and cytology-specific prompt optimization. We discuss a major paradigm shift where human pathologists may transition from actively hunting for disease to acting as "algorithmic auditors" whose primary job is to filter out the hyper-vigilant machine's noise,.Key Takeaway: Current multimodal LLMs are not yet reliable for independent Pap test interpretation due to critical blind spots and tendencies to overcall lesions,. However, their out-of-the-box performance establishes a staggering baseline. By understanding their unique mechanical flaws, pathologists can prepare to use these systems as highly effective co-pilots, seamlessly combining the algorithm's computational brute force with the indispensable filter of human medical reasoningSupport the showGet the "Digital Pathology 101" FREE E-book and join us!

Send me a derm question or story!Feline dermatology be tricky and daunting. It is easy to skip over simple steps that can make a big difference in your allergic cat management. In this episode, we break down four of the most common missteps that in managing feline skin cases.First, we tackle how to be ABSOLUTELY sure you have eliminated flea allergy dermatitis as a cause of pruritus. Next, we explore how cats express skin disease in unique ways that can be missed by owners and veterinarians such rodent ulcers.We dive into inappropriate diagnosis of food allergies, explaining why true elimination diet trials are essential and often done incorrectly. Finally, we emphasize the importance of not skipping basic diagnostics like cytology and fungal testing—foundational steps that are sometimes overlooked in favor of quick treatments such as steroids.Whether you're a practicing veterinarian or a student, this episode can give you easy tips to implement in the clinic tomorrow for your itchy cat patients!Timestamps00:00 Intro02:22 Fleas and Ectoparasites06:33 Recognizing Unique Lesions08:50 Overdiagnosing10:58 Skipping Basic Diagnostics13:23 Summary15:48 Outro

Presented by the ASC Research and Current Concepts Committee  Vicki Jo, MD, Chair & Amy Ly, MD, Vice Chair The Advances in Thyroid Cytology Award recognizes the abstract presentation that best contributes to the knowledge of diagnosis and treatment of thyroid diseases using FNA and/or ancillary techniques. This award is reviewed and selected by the ASC Research and Current Concepts Committee, given that either the primary author or a co-author is an ASC member in good standing or must have submitted a completed membership application. This award is supported by an educational grant from Thyroid Cytopathology Partners, Austin, Texas   Dr. Hamza Gokozan interviewed Dr. Neha Seth, the winner of The Advances in Thyroid Cytology Award. This interview delves into the steps that led to this award-winning platform.   Poster 13   Can Cytology Professionals Reliably Interpret TIRADS (Thyroid Imaging Reporting and Data System)? A Pilot Study on Ultrasound Guided (USG) Thyroid Nodules   Neha Seth, MD Northwell Health Greenvale, New York Hamza Gokozan, MD Member, Research & Current Concepts Committee The Ohio State University Columbus, Ohio Call for Abstracts for Platform and Poster Presentations DEADLINE TO SUBMIT ABSTRACTS - May 1, 2026 Click here to submit.

Send me a question or story!Periocular dermatitis can occur for a multitude of reasons. The first step is to figure out if the eye itself is involved or not. Once we know the eye is healthy, it is time to figure out why the SKIN AROUND the eye is losing hair, crusty, itchy, etc.It is important to return to the basic diagnostics. Cytology can be sampled with tape (if the lesion is dry) or swab (if the lesion is wet) to not risk damaging the eye. A trichogram can be used instead of a skin scrape to also protect the eye from a scalpel blade!Anything that can cause folliculitis to other areas of the skin can impact the periocular dermatitis. Allergies, mites, dermatophytosis, pyoderma, yeast dermatitis, autoimmune diseases and neoplasia can cause lesions. Dive into the details on this week's episode of The Derm Vet podcast!Timestamps00:00 Intro03:00 Periocular Dermatitis05:21 Cytology Techniques06:45 Allergies and Facial Pruritus08:20 Demodex12:00 Biopsy13:20 Neoplasia16:00 Outro

Actinomyces species are considered part of the normal vaginal and urogenital tract flora. The percentage of Pap smears containing Actinomyces-like organisms varies but is most commonly reported as approximately 7% among women using IUDs. That number is supported by multiple sources, including the Infectious Diseases Society of America guideline and several clinical studies. The incidence can be higher or lower depending on the type of IUD; for example, copper IUDs have been associated with rates up to 20%, while levonorgestrel-releasing IUDs show lower rates around 2.9%. In women with an IUD, who are found to have this finding on their liquid-based Pap smear, what is the appropriate management? In this episode, which comes from one of our podcast family members, we will discuss this topic and it's management in both symptomatic and symptomatic (pelvic pain) IUD wearing women. 1. McHugh KE, Sturgis CD, Procop GW, Rhoads DD. The Cytopathology of Actinomyces, Nocardia, and Their Mimickers. Diagnostic Cytopathology. 2017;45(12):1105-1115. doi:10.1002/dc.23816.2. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstetrics and Gynecology. 2017;130(5):e251-e269. doi:10.1097/AOG.0000000000002400.3. Miller JM, Binnicker MJ, Campbell S, et al. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2024; ciae104. doi:10.1093/cid/ciae104.5. Carrara J, Hervy B, Dabi Y, et al. Added-Value of Endometrial Biopsy in the Diagnostic and Therapeutic Strategy for Pelvic Actinomycosis. Journal of Clinical Medicine. 2020;9(3):E821. doi:10.3390/jcm9030821.

Chapter 1 – “Lumps, Not Bugs: Cracking the ‘Sterile' Case” 03:22 – John welcomes Dr Laura Buckley back for part two on brachycephalic skin disease and tees up two topics: Sterile Granuloma/Pyogranuloma Syndrome (SGPS) and Muzzle Folliculitis/Furunculosis, plus how to manage comorbidities. Laura explains it's an uncommon, immune‑mediated nodular skin disease of dogs involving histiocytic cells (macrophages). No infectious agent is found and it responds to immunomodulatory therapy. 04:43 – Sue asks which brachy breeds are most affected and typical ages. Laura most often sees Boxers, British Bulldogs, some Mastiffs and (in her clinic) many Staffordshire Bull Terriers. Usual onset is middle‑aged, though younger dogs can be affected. 05:21 – Sue asks what it looks like. Laura: papules, nodules or plaques (mm to several cm), localised or generalised; often on trunk, but head/limbs too. Typically non‑painful and non‑pruritic; may be erythematous, haired or alopecic; sometimes eroded/ulcerated with crusting - the key is a nodular process. 07:20 – Sue asks for key differentials. Laura highlights superficial bacterial folliculitis as the big rule‑out in short‑coated brachys (tufted hairs). Cytology helps: infection shows neutrophils with intracellular cocci (staphylococci); a sterile process shows inflammatory cells without bacteria. 07:49 – Laura notes most SGPS nodules are intact, so fine‑needle aspirates (multiple nodules) are preferred over impression smears. Expect many neutrophils and macrophages; bacteria should be absent. 08:23 – Sue asks about deep fungal disease and other infections. Laura: you can't reliably exclude on cytology alone—next step is biopsy. Remove a whole nodule if possible so histopathology can section through it and use special stains for atypical organisms (bacteria, deep fungi, parasites, protozoa). This thorough exclusion is critical before immunosuppression. 10:11 – Sue asks how to submit samples. Laura often splits: submit an entire nodule (or half) in formalin for histopathology and keep a second small sample (e.g., 4 mm punch from another lesion) chilled/frozen pending culture. Direct to bacteriology or mycology depending on histopath hints. 11:01 – John asks about treatment and prognosis. Laura finds most dogs do well: disease may wax and wane but responds to therapy; rare spontaneous resolution reported. Start with glucocorticoids (prednisolone). Typical immunosuppressive dose 2–4 mg/kg (sometimes 1–1.5 mg/kg suffices; she often starts at 2 mg/kg). If response is poor or steroid side effects are problematic, add cyclosporine at 5 mg/kg once daily; azathioprine has been used. For localised lesions, topical hydrocortisone aceponate spray can help. 13:24 – Sue asks for a prednisolone protocol. Laura: baseline haematology/biochemistry/urinalysis before starting. Recheck at 2–3 weeks for tolerance and early response; continue same dose another 2–3 weeks to resolution, then taper by ~20% every couple of weeks. Once down to ~0.5 mg/kg, move to alternate‑day dosing. Add cyclosporine if lesions recur on taper to avoid long‑term steroid adverse effects (PU/PD/PP, lethargy/weight gain; long‑term risk: calcinosis cutis). With dual therapy or cytotoxics, schedule regular bloods (after 1 month, then every 2–3 months). Chapter 2 – “Chins Up: Muzzle Mayhem, Managed” 17:05 – John pivots to Muzzle Folliculitis/Furunculosis: what is it and who gets it? Laura: a bacterial follicular disease confined to the muzzle skin, common in coarse/bristly‑coated brachys—British & French Bulldogs, Pugs, Shar‑Pei, Boxers. 18:04 – John asks what drives it. Laura: often linked to allergic skin disease; facial folds create many “mini‑intertrigo” sites. Pruritus → rubbing/trauma to bristly follicles. She suspects a sterile inflammatory start that quickly progresses to secondary bacterial folliculitis. 20:13 – Sue asks if this is the same as acne. Laura: no - acne is a keratinisation disorder (e.g., plugged follicles; classic in cat chins). Muzzle folliculitis/furunculosis is follicular inflammation progressing to follicle rupture (furunculosis) with foreign‑body reaction. Clinically it's more diffuse over chin/muzzle with erythema, alopecia, papules/pustules, erosions/ulcers/crusts; severe cases show haemorrhagic bullae‑like lesions—“an interdigital cyst on the chin.” 23:24 – John asks about diagnosis and first‑line management. Laura: clinical pattern + cytology to confirm/grade infection. Prioritise topical antiseptics; address primary disease and contributing behaviours (chewing cages/toys, environment). Systemic antibiotics only if deep/severe infection and ideally based on culture. 25:02 – Sue asks preferred topicals. Laura: chlorhexidine‑containing products are mainstay; ethyl lactate also helpful. Choose gentle vehicles (mousses/wipes) for faces; shampoos are good for debris removal but impractical on muzzles. Educate owners to avoid mechanical trauma. Benzoyl peroxide was useful historically but isn't currently available in the UK. Topical clindamycin/fusidic acid can work, but antiseptics usually outperform; always control inflammation alongside antimicrobials. Chapter 3 – More than a twofold problem: Comorbidities Without Chaos 29:52 – Sue asks about juggling comorbidities (e.g., SGPS plus history of demodicosis). Laura: set expectations with owners; if on isoxazoline preventatives, relapse of demodex during immunosuppression is unlikely but monitor closely. Risk is higher during combination immunosuppression (e.g., pred + cyclosporine) and lower on single‑agent maintenance. 32:15 – Sue asks about surveillance. Laura: in addition to haematology/biochemistry and urine checks, perform periodic hair plucks/skin scrapes to rule out demodex whenever new alopecic lesions appear or during ongoing therapy. Any follicular disease (including muzzle furunculosis) warrants demodex checks. 33:18 – Closing remarks. Sue and John thank Laura; they note the focus on common, real‑world brachy problems (intertrigo, muzzle folliculitis, seasonal flank alopecia, SGPS) and the importance of pragmatic, owner‑friendly routines.

Send us a textLive from Pathology Visions 2025 in San Diego, I share highlights from Day 2 of the world's leading digital pathology conference, where experts explored how AI, empathy, and training are shaping the next generation of pathologists.This episode captures the shift from technology as a tool to technology as a bridge — helping us connect with patients in more meaningful ways.What I Talk About1️⃣ From Pixels to Patients We've built the infrastructure; now it's about applying it. Pathology is no longer just digital — it's personal, accessible, and human-centered.2️⃣ Dr. Leah Lijah Joseph's Keynote — Pathologists as Patients Dr. Joseph, a cancer pathologist and survivor, shared her journey from diagnosing others to understanding her own slides. She now runs a patient pathology clinic, empowering people to see and learn from their own tissue samples.3️⃣ The Power of Visualization Dr. Joseph described how visualization and mental imagery support healing — a reminder that empathy and imagination can coexist with precision science.4️⃣ AI & Imaging Innovation From Google Research's JPEG AXL format reducing file size by 30%, to discussions on color fidelity with DICOM's David Clooney, we explored how innovation and accuracy must move hand-in-hand.5️⃣ Cytology Goes Digital With Hologic's Genius Digital Diagnostic and AIXMed's AI-assisted QC, cytology is entering a new era — faster, more accurate, and fully traceable through 100% AI quality control.6️⃣ The Human Side of AI I also share a personal story about my mother's medical experience — and how even with all the tech, empathy remains the missing link. AI can't replace compassion, but it can help us focus on it by automating what takes time away from patients.Key TakeawaysAI is enhancing accuracy and accessibility in diagnostics.Pathologists are taking on more patient-facing roles.Cytology digitization is revolutionizing quality and speed.Innovation must balance efficiency with color and data integrity.Empathy and communication will always define great medicine.I hope this episode helps you see how AI, empathy, and education are shaping the next era of diagnostics.Let's continue building the bridge from pixels to patients, one slide at a time.

Few diagnostics have the power to both strengthen client trust and change patient outcomes as quickly as cytology does. In this episode of the Clinician's Brief Partner Podcast, Dr. Beth is joined by Dr. Cory Penn and Dr. Mollyann Holland to discuss how artificial intelligence (AI) technology is changing our approach to cytology and removing long-standing barriers in practice.Sponsored by ZoetisContact us:Podcast@instinct.vetWhere to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.brief The Team:Beth Molleson, DVM - HostSarah Pate - Producer & Project Manager, Brief StudioTaylor Argo - Podcast Production & Sound Editing

Send us a textWhat if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outperforms us.Episode Highlights:[00:02:49] Neuropathology image analysis (Boston VA & BU) – Why traditional semiquantitative scoring often fails, and how AI-based density quantification reveals more subtle pathology in CTE.[00:13:16] Chronic kidney changes with AI (Mayo Clinic, Cambridge, Emory, Geneva) – A 20-class AI model trained on 20,500 annotations, showing how multiclass segmentation outperforms human guesswork in renal pathology.[00:21:09] Digital hematology review (University of Pennsylvania) – Current hurdles in AI for blood and bone marrow evaluation: regulatory oversight, data standardization, and resistance to change.[00:25:52] AI in cytology review (Journal of Cytopathology) – From BD FocalPoint to deep learning: two decades of digital cytology, stagnation, and why adoption still lags despite proven benefits.[00:32:09] Neuropathology goes digital – Where digital neuropathology is already routine (Ohio State, Mayo Clinic, Leeds, Granada) and why this specialty is crucial for pushing adoption.[00:34:19] Personal note – Why I believe learning, sharing, and experimenting with AI tools now will shape the way we practice pathology tomorrow.Resources from this EpisodeComparison of quantitative strategies in neuropathologic image analysis – Boston VA / BU Brain Bank study.Multiclass AI model for chronic kidney changes – Mayo Clinic, Cambridge, Emory, Georgia Tech, Geneva collaboration.Review: Digital hematology in the AI era – International Journal of Laboratory Hematology.Review: AI and machine learning in cytology – Journal of the American Society of Cytopathology.Digital Pathology 101 (by me, Dr. Aleksandra Zuraw) – Free PDF & Amazon print edition.Pathology AI Makeover Course – Practical training for AI in pathology workflows.Support the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

I love getting your questions and answering them on the podcast. This week is one of my favorite topics: cytology! What tips do I have for direct impression smear vs. tape prep?How do I know the appropriate treatment based on quantity of infectious organisms?What is the difference between superficial pyoderma and deep pyoderma?Get your questions answered on this week's episode of The Derm Vet podcast!TIMESTAMPS00:00 Intro01:22 What advice do you have for collecting tape prep versus collecting direct impressions?03:47 Tape prep07:06 How to stain tape prep08:43 How can we get better at sampling interdigital spaces?11:16 Dry Lesion vs Wet Lesion14:15 How do you interpret the number of Malassezia or bacteria on skin or ear cytology?17:13 How do you differentiate between a deep pyoderma and a superficial pyoderma?20:00 How many organisms do you consider 1 plus, 2 plus, 3 plus?22:20 Thoughts on AI/Digital cytology machines24:34 Outro

Dive into the minds behind the award-winning Cytology Shark Tank, which redefines innovation. This episode features behind-the-scenes insights and transformative ideas from creators who will make a lasting impact. This podcast turns achievements into lessons that spark change, perfect for thought leaders, dreamers, and doers. Listen, learn, and be inspired! Dr. Taryn L. Waraksa-Deutsch interviews Ms. Michele Smith, 2024 Cytology Shark Tank winner, along with Ms. Donna Russell and Dr. Catherine Bammert, who were part of the award-winning team. Michele A. Smith, MS, SCT(ASCP) Winner - 2024 Cytology Shark Tank University of Wisconsin-Madison Madison, Wisconsin Donna K. Russell MEd CT(ASCP) HT(ASCP) University of Rochester Medical Center Rochester, New York Catherine E. Bammert, PhD, CT, MBASCP, CTIAC UT MD Anderson Cancer Center Houston, Texas Taryn L. Waraksa-Deutsch, DHSc, SCT(ASCP), CFIAC ASC Research and Current Concepts Committee, Member Fox Chase Cancer Center Philadelphia, Pennsylvania

Send us a textYou think going digital in pathology just means buying a scanner? Think again. In this episode sponsored by Epredia, I sat down with Ryan Davis, Director of Global Business Strategy at Epredia, to talk about what it really takes to implement digital pathology—and why modularity, cytology support, and AI integration are changing the game. Whether you're starting your digital journey or scaling up with advanced tech, there's something in this conversation for you.

Presented by the ASC Research and Current Concepts Committee  Vicki Jo, MD, Chair & Amy Ly, MD, Vice Chair Dr. Esma Ersoy interviewed Dr. Caddie Laberiano Fernandez, the winner of the Quality Improvement in Cytology Award. This interview dives into the steps that led to this award-winning platform. Platform 12 Standardizing Pre-analytic Factors in Cytology Specimens for ICC Evaluation and Their Assessment Using Image Analysis Caddie Laberiano Fernandez, MD MD Anderson Cancer Center Houston, Texas Esma Ersoy, MD ASC Research and Current Concepts Committee, Member University of Connecticut Health Farmington, Connecticut Call for Abstracts for Platform and Poster Presentations DEADLINE TO SUBMIT ABSTRACTS - May 1, 2025  Click here  [cytopathology.org]to submit.

Presented by the ASC Research and Current Concepts Committee  Vicki Jo, MD, Chair & Amy Ly, MD, Vice Chair Dr. Cathy Bammert interviewed Dr. Lakshmi Harinath, the Geno Saccomanno, MD, New Frontiers in Cytology Award recipient. This interview explores the steps that led to the development of this award-winning platform. Platform 8 Analysis of Sensitivity of High-Grade Squamous Intraepithelial Lesion (HSIL) Pap Diagnosis and Interobserver Variability with Hologic Genius Digital Diagnostics Lakshmi Harinath, MD, MPH University of Pittsburgh Medical Center Pittsburgh, Pennsylvania Catherine E. Bammert, PhD, CT, MBASCP, CTIAC ASC Research and Current Concept Committee, Member UT MD Anderson Cancer Center Houston, Texas  Call for Abstracts for Platform and Poster Presentations DEADLINE TO SUBMIT ABSTRACTS - May 1, 2025  Click here to submit.

It can be difficult to differentiate pemphigus foliaceus (PF) in certain cases. If there is a lot of infection or inflammation, it can be difficult to tell if the case is autoimmune or allergic. However, there are a few hints between dogs and cats that can give you an indication you are dealing with PF.In dogs, honey colored adherent crusting, facial lesions, nasal planum involvement and crust paw pads can occur with PF. In cats, purulent debris at the claw folds, crusting/erythema around the nipples and crusting/erythema to the pinna can be hints of PF.As always, check cytology and look for neutrophilic inflammation without infection and/or acantholytic keratinocytes (prematurely lifted skin cells). Learn more details on this week's episode of The Derm Vet podcast!TIMESTAMPS00:00 Intro01:53 Dogs and Pemphigus04:29 Oral Mucosa06:00 Cats and Pemphigus09:53 Cytology and Pemphigus 12:53 Summary

Join our Moderator, Dr. Neharika Shrestha, and Guest Speaker, Dr. Swikrity U. Baskota, in this enriching podcast episode as they discuss the fascinating topic, which is a beginner's guide to Breathing Easy Through Respiratory and Lung Cytology.  Click here to view this podcast and its PowerPoint presentation, now available for everyone on our ASC YouTube Channel, CytoPath1951. We believe in making valuable information accessible to all. Moderator: Neharika Shrestha, MD Resident Physician (PGY-3) Department of Pathology & Laboratory Medicine Albany Medical Center Albany, New York Guest Expert Speaker: Swikrity U. Baskota, MD Chair, The ASC Bulletin & CytoPathPod Editorial Board Assistant Professor Department of Pathology & Laboratory Medicine UC Davis Medical Center Sacramento, Calforina

Presented by the ASC Research and Current Concepts Committee  Vicki Jo, MD, Chair & Amy Ly, MD, Vice Chair Dr. Heather Chen-Yost interviewed Dr. Abdol Aziz Ould Ismail, the winner of the Advances in Thyroid Cytology Award. This interview delves into the steps that led to this award-winning platform. Platform 6  Impact of a Comprehensive Quality Improvement Initiative for Reducing AUS Rates in Thyroid FNA Cytology: An Institutional Experience Abdol Aziz Ould Ismail, MD Dartmouth Hitchcock Medical Center Lebanon, New Hampshire Call for Abstracts for Platform and Poster Presentations DEADLINE TO SUBMIT ABSTRACTS - May 1, 2025  Click here to submit.

A common phrase around The Derm Vet is "cytology everything". But, what does that actually mean?Looks weird? Cytology.Itchy spot? Cytology.How long to treat an infection? Cytology.Things changed? Cytology.Cytology everything! Learn more on this week's episode of The Derm Vet podcast.TIMESTAMPS00:00 Intro00:25 My time at VMX04:22 Cytology Everything06:13 Where "Cytology Everything" comes from10:30 Rechecks12:39 Summary/Outro

Send us a textIn this episode of the Digital Pathology Podcast, you will learn about cytology's entrance into the digital pathology space, including successful AI and scanner implementations. We cover AI's role in rapid on-site evaluation for lung cancer and share insights on a looming prostate cancer surge and how digital pathology and AI can help. IYou will also listen to a live demo of me using an AI assistant to decode a scientific paper in real-time. Tune in to stay on top of the digital pathology research in 2025!00:00 Welcome to DigiPath Digest00:53 Introduction and New Year Greetings01:41 Diving into DigiPath Digest01:44 AI in Respiratory Cytology06:11 The Role of AI in Pathology09:49 Multi-Omics and AI11:28 Radiomics and Pathomics14:44 Live Q&A and Future Plans20:09 Prostate Cancer Tsunami22:34 Thyroid Cytology and Live AI-Assistant demo31:07 Conclusion and the option to send texts :)Links and Resources:Subscribe to Digital Pathology Podcast on YouTubeFree E-book "Pathology 101"YouTube (unedited) version of this episodeTry Perplexity with my referral linkMy new page built with PerplexityPublications Discussed Today:

Presented by the ASC Research and Current Concepts Committee  Vicki Jo, MD, Chair & Amy Ly, MD, Vice Chair Dr. Amy Ly interviews Dr. Abberly Lott Limbach the winner of the ASC Geno Saccomanno, MD New Frontiers in Cytology Award. This interview delves into the steps that led to this award-winning abstract. Platform 14 Evaluation of Oral Cytology Brushings Correlated With Histopathology with High Sensitivity for Carcinoma Abberly Lott Limbach, MD The Ohio State University Wexner Medical Center Columbus, Ohio

Get access to our clinical podcast series with our ⁠30% off IVECCS Special.⁠ I have a love-hate relationship with in-house pleural effusion analysis. Love, because it's really quite interesting, and the results can be tremendously useful for your very sick effusion patient. Hate because it can be REALLY challenging! But not anymore... This episode highlights some key takeaways from a very informative IVECCS session on how to get maximum information from your in-house effusion analysis to help you make quick and logical treatment decisions, including a real McGyver hack for doing advanced diagnostics on the cheap. ⁠Dr Holly Brown⁠ is a board certified clinical pathologist who works in a bustling general, referral, and emergency practice where she sees a wide variety of diagnostic submissions and enjoys playing an important role at the interface of diagnostics and patient care. Dr. Brown has always been passionate about delivering continuing education to doctors and technicians around maximizing laboratory testing, and she serves an important role as Chief Veterinary Educator for Antech Diagnostics.  ⁠Jessica Wilson-Hess⁠ is a certified veterinary technician and veterinary technician specialist in small animal internal medicine who nerds out on all things clinical pathology, including teaching other techs and nurses how to get really good at it. Sign up for our ⁠free weekly newsletter⁠ to hear about my favourite 3 lessons I learnt in that week from making the podcasts. Get case support from our team at specialists in our ⁠⁠Specialist Support Space⁠⁠. Topics and Time Stamps 02:18 Importance of In-House Analysis 02:48 Understanding Pleural Effusion in Cats and Dogs 05:20 Classifying Effusions: Transudate, Exudate, and More 09:59 Sample Handling and Common Mistakes12:09 Using Analyzers for Fluid Analysis 17:04 Cytology and Concentration Techniques 24:24 Understanding Centrifugation in Cytology 25:33 In-House CSF Analysis Techniques 26:59 DIY Cyto-centrifuge Using a Salad Spinner! 30:43 Manual Cell Counting Methods 33:14 Chemistry and Effusion Analysis 38:15 Identifying Neoplastic Cells 41:46 Empowering Technicians in Veterinary Practice

Presented by the Cytology Programs Review Committee Charles Sturgis, MD, Chair, & Jenna LeBlanc, MS, CT(ASCP)CM, Vice Chair Michele Smith, MS, SCT(ASCP) & Sean McNair, MPH, CT(ASCP) are members of the CPRC. Title: The Future of Cytology: A Review of the Updated Standards, Name Change, and Transition to Master's   Host Mr. Sean McNair joins Ms. Jenna LeBlanc, Ms. Michele Smith, and Dr. Charles Sturgis in this enriching episode to discuss the updates of the new Standards and Guidelines for the Accreditation of Educational Programs in Cytology, the rationale behind the profession's name change, the transition to master's degree, and the future of Cytology. This podcast pulls back the curtains to show the dedication of the CPRC and the changes they are excited to share with you. For additional information, please visit the Cytology page on the CAAHEP website (includes all four sponsors and emails, Standards, FAQs, and Curriculum Implementation Strategies): https://caahep-public-site-5be3d9.webflow.io/committees-on-accreditation/cytology

Presented by the Research and Current Concepts Committee Vickie Y. Jo, MD, & Chair Amy Ly, MD, Vice Chair Dr. Savitri Krishnamurthy interviews Dr. Lily Mahler, the winner of the ASC Advances in Thyroid Cytology Award. This interview delves into the steps that led to this award-winning abstract. Poster 89 Repeat Fine Needle Aspiration for Thyroid Nodules Classified as Follicular Neoplasm: Evaluation of Cytologic, Molecular, and Histologic Outcomes Lily Mahler, MD  Beth Israel Deaconess Medical Center  Boston, Massachusetts  

Join us in our exciting first Spanish-speaking episode! In this first ASC Spanish-speaking episode, Drs. Nora Morgenstern, Cecilia Gimenez, and Glorimar Rivera discussed a new initiative to boost cytology education in Spanish-speaking communities. The program, developed by the Professional Development, Mentoring, and Diversity Committee, aims to make cytology lectures accessible and free for the entire Spanish-speaking community. The committee gathered feedback from members of the Spanish-speaking community to adapt their approach and create a comprehensive educational plan. The program consists of cytology lectures in Spanish, considering the community members' work, social, and family commitments. Enjoy this informative and exciting endeavor. En este primer episodio de ASC en Española. Las doctoras Nora Morgenstern, Cecilia Gimenez y Glorimar Rivera discutieron una nueva iniciativa para impulsar la educación en citología en las comunidades hispanohablantes. El programa, desarrollado por el Comité de Desarrollo Profesional, Mentoría y Diversidad, tiene como objetivo hacer accesibles y gratuitas las charlas de citología para toda la comunidad hispanohablante. El comité recopiló opiniones de miembros de la comunidad para adaptar su enfoque y crear un plan educativo integral. El programa consiste en charlas de citología en español, teniendo en cuenta los compromisos laborales, sociales y familiares de los miembros de la comunidad. Disfruten de este esfuerzo informativo y emocionante.   Click here for more information and check out their article in the 2024 July issue of The ASC Bulletin titled Introducing the New initiative from the Professional Development, Mentoring and Diversity Committee.

In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics. In our keynote interview, we speak with Michael Quick, Vice President of R&D and Innovation in Cytology & Oncology at Hologic. Quick shares his journey from a pre-med student to a leader in cytology innovation. He discusses the development and impact of Hologic's Genius Digital Diagnostic Systems, the first FDA-approved digital cytology system, which leverages AI to enhance cervical cancer screening accuracy and efficiency. Michael emphasizes Hologic's dedication to women's health and the critical role of AI in addressing the shortage of skilled cytologists, ensuring faster and more accurate diagnostics for patients worldwide. He also touches on the challenges and opportunities faced during the FDA approval process and the importance of early and collaborative engagement with regulatory bodies. We also hear from Dr. Wael Yared, Chief Technology Officer at Tecan, who highlights Tecan's contributions to cancer research and diagnostics. Dr. Yared elaborates on the company's innovations in liquid biopsy and solid tissue biopsy workflows, which leverage AI to streamline processes and reduce errors. He emphasizes the significance of partnerships in driving medical advancements and the role of AI in personalized medicine and multiomic capabilities. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about Tecan visit, https://partnering.tecan.com/ Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!

Presented by the Research and Current Concepts Committee Vickie Y. Jo, MD, & Chair Amy Ly, MD, Vice Chair Dr. Heather Chen Yost interviews Dr. Robert Post, the winner of the ASC Quality Improvement in Cytology Award. This interview will take you on a journey with this award-winning poster. Using Natural Language Processing and Machine Learning Techniques for Cytology-Histology Correlation Saves Cytotechnologist Time without Compromising Quality Robert Post, DO Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Host: Jennifer Caudle, DO Guest: Tamera A. Paczos, MD, FACOG, FACP The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories. COBAS and CINTEC are trademarks of Roche.All other product names and trademarks are the property of their respective owners. 02/23

Join host Dr. Dina Zenezan and Dr. Israh Akhtar in this enriching podcast episode as they illuminate the fascinating domain of cytopathology with a particular focus on the GYNPAP test. Pulling back the curtains on complex cytological concepts, Dr. Akhtar offers an invaluable guide to the liquid-based preparation systems predominantly employed in the US - the thin prep and short path. Dr. Akhtar leaves no questions unanswered, simplifying the complexity of cytopathology and its immense relevance to overall human health. Further your learning by exploring the suggested reading materials for a more profound examination of candida, trichomonas, and squamous cell conditions. To view this presentation with slides click here. Resources

One of the top questions I get asked... "How do I get better cytology samples?". This week's episode of The Derm Vet podcast goes over some Dos and Don'ts to improve your cytology collection technique to get amazing samples!DO: use your non-dominant hand to assistDO: get under crust and scaleDO: practiceDO: use different collection techniquesDON'T: be wimpy with your samplingDON'T: skip itDON'T: rub the slide back and forthDON'T: give upTIMESTAMPSIntro 00:00The Do's Of Cytology 01:03The Don'ts of Cytology 08:36Outro 15:38

A preview of one of my lectures coming up this summer at the World Congress of Veterinary Dermatology (WCVD)... Managing dermatologic diseases can be frustrating and costly for pet owners due to the chronicity of diseases and ongoing treatment required for many patients. Secondary issues such as pyoderma and otitis are also common issues that can be recurrent and add to unexpected costs. There are many different aspects of management that can cost money such as pharmaceuticals, topicals, diagnostics, nutrition, parasiticides and supplements. How can dermatologists and general practitioners utilize appropriate tools to lessen the costs long-term for pet owners? Learn how to keep dermatology management CHEAPer by utilizing Cytology, History, Examination, Assessment and Plan. TIMESTAMPSIntro 00:00My New Lecture For WCVD10 00:28How To Make Dermatology C.H.E.A.P. 01:56C)ytology 04:00H)istory 06:49E)xamination 08:44A)ssessment 11:18P)lan 13:26Outro 17:06

The Daily Quiz - Science and Nature Today's Questions: Question 1: What is Cytology the study of? Question 2: What is a female alligator known as? Question 3: What is Orthopterology the study of? Question 4: What is the name of the process that is concerned with the development of the fertilized egg and the growth of the fetus? Question 5: What is Zymology the study of? Question 6: What is the heaviest element that can be formed by regular fusion reactions in the core of a star? Question 7: Which type of tree is known for its fragrant, yellowish-green flowers? Question 8: Which substance has the chemical formula H2SO4? This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you ever been at a conference, asked a dermatologist a question and get the dreaded answer.... "it depends"?Why can't we commit to a more clear cut answer for you? Find out why on this week's episode of The Derm Vet podcast.

It is so important to learn new skills and change your way of doing things. This is not only best for the pet you are treating, but makes dermatology more fun for you! Learn about some of the ways I have changed my derm practice on this week's podcast episode!

Ear cultures are a bit controversial in veterinary dermatology. Do you know why? Check out this week's episode of The Derm Vet podcast to find out!

Sponsored by Zoetis. Head to dvm360 Flex and login or create a free CE account and claim your credit after listening to this episode. Program Description This course covers key diagnostic, treatment and communication elements involved in successful diagnosis and effective treatment of acute and chronic canine allergic dermatitis.   Program Agenda   Key elements in diagnosis of canine pruritus and treatment of allergic dermatitis Stop the pruritus: we will discuss features of both Apoquel® (oclacitinib tablet) and Cytopoint® to clarify decision-making in the acute and chronic phasis of allergic dermatitis, and flexible dosing of Apoquel. Assessment and interpretation of Apoquel and/or Cytopoint perceived treatment failures will be discussed. Assess for ectoparasites: diagnostic techniques as well as the importance of trial ectoparaciticidal therapy will be discussed with a focus on the isooxazoline class. Assess for and treat secondary infections: Cytology will be discussed including tips to leverage your technicians in the diagnostic process as well as VetScan Imagyst™ technology. Key elements in the management of chronic allergic dermatitis Communication tips will be discussed, including key concepts and statements to maximize understanding and compliance.  Anchor therapies and supportive therapies for management of chronic atopic dermatitis and perceived failure of previously successful anchor therapy                      Learning Objectives Investigate flare factors to assess increases in itch in previously controlled atopic dogs. Outline the key elements in the diagnosis of allergic dermatitis and communicate a diagnostic plan to a client or colleague. Develop a long-term treatment plan for a patient with chronic atopic dermatitis including anchor and supportive therapies. Construct a treatment plan to control allergic pruritus during an ectoparasite or elimination diet trial, and discontinue therapy to interpret the results. Evaluate history, diagnostic findings, patient and client needs to synthesize an optimal anchor therapy or therapy for an allergic flare.

In this episode, CardioNerds co-founder Amit Goyal joins Dr. Iva Minga, Dr. Kevin Lee, and Dr. Juan Pablo Salazar Adum from the University of Chicago - Northshore in Evanston, IL to discuss a case of primary cardiac diffuse large B-cell lymphoma. The ECPR for this episode is provided by Dr. Amit Pursnani (Advanced Cardiac Imaging, Fellowship program director, NorthShore University HealthSystem). Audio editing by CardioNerds Academy Intern, Dr. Akiva Rosenzveig. Case synopsis: A 77-year-old man with no significant medical history presents to the emergency department with progressive shortness of breath for 1 week. He reports an unintentional 15-pound weight loss in the prior month as well as constipation and abdominal/flank pain. On examination he was found to be tachycardic with a regular rhythm and further evaluation with a chest X-ray and chest CT scan demonstrated a large pericardial effusion. This was further investigated with an urgent echocardiogram that revealed a large pericardial effusion with a large mass attached to the pericardial side of the RV free wall, as well as signs of early cardiac tamponade. A pericardiocentesis was performed and 550mL of bloody fluid was withdrawn. The fluid was sent for laboratory analysis and cytology. A cardiac MRI demonstrated a large invasive mass in the pericardium and RV wall consistent with cardiac lymphoma. Cytology confirmed diffuse large B-cell lymphoma. Subsequent CT and PET scans did not find any other site of malignancy, giving the patient a diagnosis of primary cardiac diffuse large B-cell lymphoma. The patient underwent R-CHOP chemotherapy and was followed closely with repeat cardiac MRI and PET scans which demonstrated resolution of the cardiac mass at his one-year surveillance follow-up. This case was published in US Cardiology Review, the official journal of CardioNerds. To learn more, access the case report article here. CardioNerds is collaborating with Radcliffe Cardiology and US Cardiology Review journal (USC) for a ‘call for cases', with the intention to co-publish high impact cardiovascular case reports, subject to double-blind peer review. Case Reports that are accepted in USC journal and published as the version of record (VOR), will also be indexed in Scopus and the Directory of Open Access Journals (DOAJ). CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls - A Mystery Mass in the Heart - Cardiac Lymphoma The most common cause of malignant cardiac masses is metastasis. Primary cardiac tumors are rare. Cardiac tumors are separated into 2 categories: benign and malignant. They are often differentiated based on their location and their degree of tissue invasion. Multimodality imaging is essential in the diagnosis, management, and surveillance of cardiac masses. A multidisciplinary team approach is invaluable for management of patients with cardiac tumors. Show Notes - A Mystery Mass in the Heart - Cardiac Lymphoma 1. What is the clinical presentation of cardiac masses? Cardiac masses can have a variable presentation. They can present with arrhythmias, angina, heart failure symptoms, or pericardial effusion. Patients can also be asymptomatic; the masses can be found incidentally on cardiac or chest imagining. 2. What is the differential diagnosis for cardiac masses? Cardiac masses are separated into benign and malignant. The most common malignant cardiac masses are metastases from a distant source. The location of the mass is important in narrowing the differential. 3. What imaging modalities are used to diagnose cardiac masses? Multimodality imaging is needed to describe the mass in detail and guide diagnosis. An echocardiogram is usually the first imaging modality. Cardiac MRI is a great modality that allows for the...

If most ear products have ingredients to address bacteria, yeast and inflammation, then why is ear cytology important? check out this week's episode of The Derm Vet podcast!

This week, Henry, Kate, Gary and Mark discuss: treating to LDL target or intensity-based statin therapy for adults with CAD, genicular nerve blocks for pain relief in adults with DJD, the value of adding cytology to HPV for cervical cancer screening, and HCTZ for preventing kidney stone recurrence 

Are you confident in cytology? It is the minimum database for dermatology case!Refresh yourself on cytology collection techniques with this week's episode of The Derm Vet podcast. Remember... you don't have to use them all! Find the few you love and stick with them.

2022 has been quite a year! Here is the annual wrap up episode of The Derm Vet podcast. Highlighting the top things you all have learned from the podcast this year when I asked on social media. Thanks for another wonderful year!